NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-DE-20-014 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-20-103 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is designed to support highly integrated research teams of three to six PD/PIs to address ambitious and challenging research questions that are important for the mission of NIGMS and are beyond the scope of one or two investigators. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Project goals should not be achievable with a collection of individual efforts or projects. Teams are encouraged to consider far-reaching objectives that will produce major advances in their fields. Applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies or infrastructure development are not appropriate for this FOA. This FOA is being reissued to allow submission of applications that include NIH defined clinical trials. NIGMS will not accept clinical trials that are designed to test safety and efficacy of interventions (Phase I, Phase II, Phase III) for the purpose of future clinical treatment and/or regulatory approval in response to this FOA.
Funding Opportunity PAR-20-102 from the NIH Guide for Grants and Contracts. The National Institute of General Medical Sciences (NIGMS) invites applications for Institutional Development Award (IDeA) Networks of Biomedical Research Excellence (INBRE) awards from investigators at biomedical research institutions that award doctoral degrees in the health sciences or sciences related to health or at independent biomedical research institutes with ongoing biomedical research programs funded by the NIH or other Federal agencies within the IDeA- eligible states. The purpose of the INBRE program is to augment and strengthen the biomedical research capacity of IDeA-eligible states. The INBRE program represents a collaborative effort to sponsor research between research intensive institutions and primarily undergraduate institutions, community colleges, and Tribally Controlled Colleges and Universities (TCCUs), as appropriate.
Notice NOT-AT-20-008 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AI-19-074 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the NIAID Childhood Asthma in Urban Settings Clinical Research Network Leadership Center (CAUSE-LC). The CAUSE-LC will provide the overall scientific strategy and organizational structure to the CAUSE Clinical Research Network and will interact closely with the CAUSE Clinical Research Centers (CAUSE -CRCs) to support the conduct of multi-site clinical studies and trials with the ultmate goal of developing effective interventions or asthma prevention approaches applicable to children residing in low-income urban settings.
Funding Opportunity RFA-AI-19-073 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the NIAID Childhood Asthma in Urban Settings Clinical Research Network Clinical Research Centers (CAUSE-CRCs). The CAUSE-CRCs wlill conduct both network-wide and site-specific clinical studies and trials with the ultimate goal of developing effective asthma treatment or prevention approaches applicable to children residing in low-income urban settings. For network-wide clinical research projects and other network functions, the CAUSE-CRCs will work closely with the CAUSE Leadership Center (CAUSE-LC).
Funding Opportunity RFA-ES-20-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for Environmental Health Sciences Core Centers (EHS CC). As intellectual hubs for environmental health research, the EHS CC is expected to be the thought leaders for the field and advance the goals of the NIEHS Strategic Plan (http://www.niehs.nih.gov/about/strategicplan/).The Core Centers provide critical research infrastructure, shared facilities, services and/or resources, to groups of investigators conducting environmental health sciences research.
Notice NOT-DC-20-001 from the NIH Guide for Grants and Contracts
Notice NOT-AT-20-007 from the NIH Guide for Grants and Contracts
Notice NOT-CA-20-027 from the NIH Guide for Grants and Contracts
Notice NOT-AA-20-003 from the NIH Guide for Grants and Contracts
Notice NOT-MH-20-032 from the NIH Guide for Grants and Contracts
Notice NOT-GM-20-014 from the NIH Guide for Grants and Contracts
Notice NOT-HL-20-749 from the NIH Guide for Grants and Contracts
Notice NOT-AA-20-002 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-20-077 from the NIH Guide for Grants and Contracts. With this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each application submitted in response to this FOA must consist of at least three research projects and an Administrative Core. The projects must share a common central theme, focus, and/or overall objective.
Funding Opportunity RFA-AG-21-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U24 Cooperative Agreement applications aiming to establish several mis-folded protein polymorphisms resource networks in the area of Alzheimer's disease and its related dementias (AD/ADRD). The central goal of these resource networks is to standardize and distribute seed, oligomers, and fibrils to other investigators in order to clarify and improve the reproducibility of experiments in AD/ADRD. For the past several years, many studies have developed assays and reagents to understand the biophysical properties of various tau and A structural variants such as oligomers, protofibrils, and fibrils. As a result, many imaging, chemical, and immunological tools have been developed to detect different types of A and tau polymorphs. Establishing standards, understanding the pathological roles of these protein polymorphs, and using newly developed analytic tools to address the direct correlation between patient-to-patient variations in A and tau polymorphs are the long-term goals of the resource networks supported by this FOA.
Notice NOT-HD-20-004 from the NIH Guide for Grants and Contracts
Notice NOT-AR-20-014 from the NIH Guide for Grants and Contracts
Notice NOT-AT-20-003 from the NIH Guide for Grants and Contracts